AEMCOLO

Post-LOE

rifamycin sodium

Cosmo Pharmaceuticals
NDAORALTABLET, DELAYED RELEASEPriority Review
Approved
Nov 2018
Lifecycle
Post-LOE
Competitive Pressure
35/100

Loss of Exclusivity

LOE Date
Nov 16, 2023
28 months ago
Exclusivity Expiry
Nov 16, 2028
Company
Cosmo Pharmaceuticals
Cosmo Pharmaceuticals
Ireland - Dublin
4 open jobs
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers